text_1: Risk of cardiovascular events can be cut by a third by using antihypertensive drug therapy among hemodialysis patients.
text_2: Patients on long-term dialysis participating in randomized, controlled trials and receiving antihypertensive drug therapy were the subject of this meta-analysis.